BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Treatment
47 results:

  • 1. Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell lung cancer in Administrative Claims Databases.
    Patel SP; Wang R; Zhou SQ; Sheinson D; Johnson A; Lee JS
    JCO Clin Cancer Inform; 2024 Mar; 8():e2300165. PubMed ID: 38502111
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Surgical Outcomes in Non-Small Cell lung cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
    Park S; Choe J; Lee SM; Choi S; Kim MJ; Chae EJ; Seo JB
    Ann Surg Oncol; 2024 May; 31(5):3448-3458. PubMed ID: 38386197
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Non-small cell lung cancer chemotherapy treatment outcomes and ethnicity: a twenty-year single-centre patterns of care study.
    Nguyen H; Keenan R; Kennedy I; Lao C; Lawrenson R
    N Z Med J; 2023 Nov; 136(1585):24-34. PubMed ID: 37956355
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Value of Nivolumab Clearance in Non-Small Cell lung cancer Patients for Survival Early in treatment.
    Otten LS; Piet B; van den Haak D; Schouten RD; Schuurbiers M; Badrising SK; Boerrigter E; Burgers SA; Ter Heine R; van den Heuvel MM
    Clin Pharmacokinet; 2023 Dec; 62(12):1749-1754. PubMed ID: 37856040
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score-matched NCDB Analysis.
    Cantrell JN; Acharya P; Vesely SK; Gunter TC
    Am J Clin Oncol; 2023 Nov; 46(11):503-511. PubMed ID: 37679872
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations.
    Ninomiya T; Ishikawa N; Kozuki T; Kuyama S; Inoue K; Yokoyama T; Kanaji N; Yasugi M; Shibayama T; Aoe K; Ochi N; Fujitaka K; Kodani M; Ueda Y; Watanabe K; Bessho A; Sugimoto K; Oze I; Hotta K; Kiura K
    Lung Cancer; 2023 Oct; 184():107349. PubMed ID: 37651927
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparative safety of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced anaplastic lymphoma kinase-mutated non-small cell lung cancer: Systematic review and network meta-analysis.
    Luo Y; Zhang Z; Guo X; Tang X; Li S; Gong G; Gao S; Zhang Y; Lin S
    Lung Cancer; 2023 Oct; 184():107319. PubMed ID: 37597303
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience.
    Rupp M; Fanton-Aita F; Snow S; Wheatley-Price P; Melosky B; Juergens RA; Chu Q; Blais N; Banerji S; Ng R; Khoudigian S; Sharma A; On PV; Liu G
    Curr Oncol; 2023 Jul; 30(7):6559-6574. PubMed ID: 37504341
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Machine Learning Classifier for Preoperative Prediction of Early Recurrence After Bronchial Arterial Chemoembolization treatment in lung cancer Patients.
    Kong C; Lai L; Jin X; Chen W; Ding J; Zheng L; Zhang D; Ying X; Chen X; Chen M; Tu J; Ji J
    Acad Radiol; 2023 Dec; 30(12):2880-2893. PubMed ID: 37225529
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A fully automatic segmentation pipeline of pulmonary lobes before and after lobectomy from computed tomography images.
    Pang H; Wu Y; Qi S; Li C; Shen J; Yue Y; Qian W; Wu J
    Comput Biol Med; 2022 Aug; 147():105792. PubMed ID: 35780601
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Associations Between Medicaid Insurance, Biomarker Testing, and Outcomes in Patients With Advanced NSCLC.
    Gross CP; Meyer CS; Ogale S; Kent M; Wong WB
    J Natl Compr Canc Netw; 2022 May; 20(5):479-487.e2. PubMed ID: 35545174
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk assessment of malignancy in solitary pulmonary nodules in lung computed tomography: a multivariable predictive model study.
    Liu HY; Zhao XR; Chi M; Cheng XS; Wang ZQ; Xu ZW; Li YL; Yang R; Wu YJ; Zhang XJ
    Chin Med J (Engl); 2021 Jun; 134(14):1687-1694. PubMed ID: 34397595
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Non-small cell lung carcinoma histopathological subtype phenotyping using high-dimensional multinomial multiclass CT radiomics signature.
    Khodabakhshi Z; Mostafaei S; Arabi H; Oveisi M; Shiri I; Zaidi H
    Comput Biol Med; 2021 Sep; 136():104752. PubMed ID: 34391002
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Comparison of Short-term Results of Preoperative Planning Combined with 
Fluorescence Video-assisted Thoracoscopic Precision Segmentectomy and Traditional Thoracoscopic Segmentectomy in the treatment of Early lung Adenocarcinoma].
    Xie M; Wang G; Xu M; Li T; Xu S; Xiong R; Fang Q
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):483-489. PubMed ID: 34120431
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cost-Effectiveness of Nivolumab Plus Ipilimumab Combined with Two Cycles of Chemotherapy as First-Line treatment in Advanced Non-Small Cell lung cancer.
    Peng Y; Zeng X; Peng L; Liu Q; Yi L; Luo X; Li S; Wang L; Qin S; Wan X; Tan C
    Adv Ther; 2021 Jul; 38(7):3962-3972. PubMed ID: 34100243
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR; Zhou S; Shaikh A; Willey VJ
    J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
    [No Abstract]    [Full Text] [Related]  

  • 17. Crizotinib for recurring non-small-cell lung cancer with EML4-ALK fusion genes previously treated with alectinib: A phase II trial.
    Harada D; Isozaki H; Kozuki T; Yokoyama T; Yoshioka H; Bessho A; Hosokawa S; Takata I; Takigawa N; Hotta K; Kiura K;
    Thorac Cancer; 2021 Mar; 12(5):643-649. PubMed ID: 33470536
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predictors of distress among patients undergoing staging investigations for suspected colorectal and lung cancer.
    Miles A; Evans REC; Taylor SA
    Psychol Health Med; 2021 Aug; 26(7):887-898. PubMed ID: 33232621
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
    Shang Y; Li X; Liu W; Shi X; Yuan S; Huo R; Fang G; Han X; Zhang J; Wang K; Dou Z; Zhang Y; Zang A; Zhang L
    Sci Rep; 2020 Nov; 10(1):20243. PubMed ID: 33219256
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pulmonary lobectomy for cancer: Systematic review and network meta-analysis comparing open, video-assisted thoracic surgery, and robotic approach.
    Aiolfi A; Nosotti M; Micheletto G; Khor D; Bonitta G; Perali C; Marin J; Biraghi T; Bona D
    Surgery; 2021 Feb; 169(2):436-446. PubMed ID: 33097244
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.